CleveMed Blogs

The FDA-cleared, physician-prescribed SleepView^® provides a convenient and cost-effective alternative for diagnosing the most common type of breathing-related sleep disorder

Cleveland, OH - October 17, 2011 - Midmark Corporation, a trusted leader in digital diagnostic devices for ambulatory care, announced a partnership with Cleveland Medical Devices, a leader in sleep diagnostics technology, launching the Midmark SleepView^® Monitor and SleepView^SM Portal.

The Midmark SleepView Monitor developed by Cleveland Medical Devices is the market’s smallest and lightest portable home sleep monitor that meets the American Academy of Sleep Medicine’s recommended channel set for Type III monitors.

The Midmark SleepView Portal offers prescribing physicians secure, HIPAA compliant online access to registered polysomnographic technologists and board-certified sleep physicians who provide scoring, professional interpretation and treatment recommendations.

Obstructive sleep apnea (OSA) is a repeated interruption of normal breathing during sleep due to a collapse of the upper airway. It is estimated to impact as many people as asthma and diabetes; yet, 85 percent of the population with the disease is undiagnosed and untreated. "There is a real need in the healthcare industry to address this large and growing clinical concern," said Tom Treon, senior product manager for Midmark. "We want to improve the effectiveness and efficiency of care for patients with OSA by providing another diagnostic option, which enables patients to be tested in the comfort of their own bed and convenience of their own home for a more natural night of sleep."

OSA does in fact hold serious health and economic consequences. Numerous studies link OSA to major chronic diseases such as stroke, heart failure, diabetes, obesity, hypertension and increased odds of serious car crash injuries. Economic studies have also shown that people with untreated OSA have 200 percent higher healthcare costs than similar people without OSA.

Midmark has entered into a strategic partnership with Cleveland Medical Devices Inc. (CleveMed) for licensing of the SleepView technology. Established in 1990, CleveMed is a leader in sleep diagnostics technology with products serving sleep labs, institutional and home settings.

Dr. Anne Eiting Klamar, President and CEO of Midmark stated, "We are very pleased to partner with CleveMed, a company that provides proven expertise in sleep disorders research and diagnostics. SleepView offers both an exciting addition to our diagnostic device portfolio and sophisticated, yet easy-to use services for our customers with the goal of providing efficient and effective patient care."

"We are very excited about our relationship with Midmark to extend sleep healthcare to patients in need", said Hani Kayyali, president of CleveMed. "Midmark is a strong and trusted brand with outstanding relationships among distribution and physicians. They offer our technology unique advantage to realizing the goal of providing patients, providers and payers with a convenient, cost-effective and high-quality solution to identifying OSA so it can be managed effectively."

For more information, please visit www.midmarksleepview.com, call 1-800-MIDMARK or contact your authorized Midmark distributor representative.

About CleveMed
SleepView is a registered trademark of and manufactured by Cleveland Medical Devices Inc. of Cleveland, OH. CleveMed develops innovative biomedical devices, and is a leader in miniaturized wireless telemetry and physiological monitoring devices. CleveMed has developed a growing range of products that address the needs of those with sleep disorders, including the Crystal Monitor PSG series, Sapphire, SleepScout, iPSG and DreamPort. CleveMed’s wireless sleep products allow sleep studies to be conducted remotely, and monitor a wide range of sleep disorder symptoms, while eliminating the need for typically bulky sleep diagnostic equipment. For more information, please visit www.CleveMed.com (Follow us on CleveMed Blogs, twitter, youtube, LinkedIn, and facebook)

About Midmark Medical
Dedicated to helping healthcare providers deliver the most efficient patient care, Midmark is redefining the future of the clinical space from the examination room to the procedure room, providing clinical solutions to redefine workflow. Its line of Midmark and Ritter Barrier-Free® examination and procedures tables, diagnostic products, sterilizers, lighting, seating and casework have become the industry standards in medical practices of all sizes, helping improve the patient experience while improving safety, ergonomics, productivity and profitability. Midmark’s IQ Digital Diagnostics System, a combination of digital diagnostic devices and software solutions, allow fast and easy capture, interpretation and retrieval of patient information for single practitioners to large physician groups integrating EHR/EMRs. In addition, Midmark’s partnership with Mortara Instrument, Inc. provides a comprehensive range of ECG solutions for the U.S. and Canada ambulatory care markets. Its Care Exchange™ Workstations help physicians’ offices easily integrate IT with digital diagnostics and electronic prescriptions. For more information, visit midmarkclinicalsolutions.com or midmark.com.

For More Information Contact:
Amy Rickard
Cleveland Medical Devices Inc.
P: 216.791.6720
arickard@clevemed.com
www.clevemed.com

Cleveland, OH - March 23, 2011 - Cleveland Medical Devices Inc. (CMDI) has announced the formation of Great Lakes NeuroTech (www.GLNeuroTech.com), a spin-off company which has acquired the rights to develop, market, and manufacture clinical motor assessment and therapy systems for the movement disorders market as well as physiological monitors for research and education markets. Great Lakes NeuroTech (GLN) will perform R&D, engineering, manufacturing, distribution, and exporting of these technologies through two divisions: Movement Disorders and Research & Education Systems.

“Cleveland Medical Devices Inc. has been growing significantly in the areas of Sleep Disorders, Movement Disorders and Research / Education products. The spin-off will allow CMDI and GLN to further focus their efforts on their core competencies and dramatically boost their commercialization efforts”, said Robert Schmidt, CMDI’s Chairman. “The portability, quality, and cost efficacy of CMDI’s sleep monitoring products and web technologies such as SleepView, eCrytsal PSG, and Sapphire are leading the future of sleep medicine. This spin off will allow CMDI to quickly expand its market presence nationally and worldwide while continuing its excellence in R&D to serve the needs of more than 40 million sleep disorders patients”, said Robert Schmidt.

“The launch of Great Lakes NeuroTech transitions a proven line of innovative medical and research systems, an expert team of engineers and researchers, and high quality manufacturing to a new organization with a focus on these core technologies” said Joseph P. Giuffrida, PhD, GLN’s President. “The transition of technologies, marketing and manufacturing for the movement disorders and research & education product lines from CMDI to GLN is expected to occur in stages over the next few months with no interruption in quality, delivery and support to CMDI or GLN.”

GLN’s Division of Movement Disorders will target Parkinson’s disease and other movement disorders through a portfolio of patient-centered diagnostic and therapy systems integrated with wireless, remote, and web based technologies. Devices to be manufactured by GLN will include KinetiSense™, Kinesia™, and Kinesia HomeView™ systems for capturing movement disorder motor symptoms both in the clinic, at home, and during clinical trials. GLN will continue to grow the product portfolio through ongoing research and development funded by the National Institutes of Health in collaboration with key clinical opinion leaders in the field of movement disorders.

GLN’s Division of Research & Education Systems will market and manufacture a line of wireless physiological monitors and intelligent analysis software targeted to research and education markets. The BioRadio™ is a general purpose physiological monitor for capturing signals such as brain waves, muscle forces and activity, electrical heart activity, respiration, galvanic skin resistance, and pulse oximetry. The BioRadio is packaged in CleveLabs™, a lab course system with sessions for teaching physiology, psychology, health sciences, and biomedical engineering principles; and BioCapture™, a general purpose physiological research system. GLN will continue to expand the growing customer base for these technologies at universities and research institutes both domestically and internationally.

About CMDI

Cleveland Medical Devices Inc.’s mission is to develop, manufacture, and market innovative sleep disorders diagnostic and therapy products that improve the quality of life and reduce total health care costs for patients around the world.

About Great Lakes NeuroTech

Great Lakes NeuroTech is committed to pioneering innovative biomedical technologies to serve research, education, and medical communities, improving access to medical technology for diverse populations, and positively impacting quality of life for people around the world.

Media Contact

Maureen Phillips
Sales & Marketing Manager
216.619.5918
mphillips@GLNeuroTech.com

KinetiSense, Kinesia, Kinesia HomeView, BioRadio, CleveLabs, and BioCapture are trademarks of Cleveland Medical Devices Inc. of Cleveland OH provided under license to Great Lakes NeuroTech.

Cleveland, Ohio – Oct 12, 2010 CleveMed, a leader in sleep disorders monitoring devices announces the launch of eCrystal PSG, its newest product. eCrystal PSG is a web portal that allows physicians to seamlessly access sleep study information and share results with other staff and specialists over a secured internet connection, creating an efficient method to detect and track sleep apnea. The web portal works hand-in-hand with a number of CleveMed home monitors like SleepView™, which records physiological data while the patient sleeps at home. Once the monitor is returned to the physician, data is uploaded to eCrystal PSG and sent to a sleep technologist for review and scoring. Via the web portal, ordering physicians can also connect with state-licensed sleep doctors for proper interpretation of the sleep study. With this product, CleveMed offers the widest range of portable sleep monitors in the market today strengthening its leading position in the market place.

“Testing for sleep apnea in the home, if conducted properly, can offer convenience for the patient, proper assessment for the provider, and cost benefit for the payer”, said Hani Kayyali, the president of CleveMed, “with the addition of the web portal, our breadth of products and services are poised to lead the way in the proper implementation of home healthcare for sleep disorders”.

“As we move forward into the next chapter in sleep medicine, it is critical that we continue to rely on the expertise of sleep physicians to ensure proper study interpretation”, said Mike Papsidero M.D., Chief Medical Officer for CleveMed. “CleveMed’s web technologies ensure great quality, convenience and connectivity to a network of sleep physicians, all of which improve patient care and maintain key advantages over the competition”.

Obstructive sleep apnea (OSA) is a disorder that prevents breathing during the night and affects more than 15 million patients. Although effective treatment exists, the vast majority of patients (80%) remain undiagnosed and untreated due to the expense and inconvenience of current testing methods. CleveMed’s family of portable sleep testing products effectively addresses this issue by facilitating evaluation in the home.

About CleveMed

CleveMed is pioneering the use of novel wireless monitoring systems for high growth neurology and rehabilitation applications. Through these innovations, CleveMed has developed a growing range of products that address the needs of the medical, research and academic communities around the world. Cleveland Medical Devices Inc.’s mission is to develop, manufacture and market rehabilitation and monitoring products that improve quality of life and allow patients to leave the hospital earlier, thus lowering total health care costs. For more information, please visit www.CleveMed.com.

For More Information Contact:

Amy Rickard
Cleveland Medical Devices Inc.
P: 216.791.6720 | F: 216.791.6739
arickard@clevemed.com
www.clevemed.com

The Cuyahoga County New Product Development and Entrepreneurship Loan Fund awarded Cleveland Medical Devices Inc. $60,000 to step up commercialization of the company’s SleepView device for sleep apnea screening at home.

CleveMed has a lineup of wireless diagnostic sleep systems, including SleepView, which is the smallest and lightest home sleep monitor with an American Academy of Sleep Medicine-recommended Type 3 channel set.

(AS SEEN ON MASS DEVICE)